News Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study Evaluating Investigational Agent TP-3654 in Patients with Myelofibrosis at American Society of Hematology 2022 Annual Dec 15, 2022 Posted by Sumitomo Pharma Oncology, Inc.
News Greenberg Traurig’s Roman Fayerberg Speaks on BBA Intellectual Property Panel Dec 15, 2022 Posted by Greenberg Traurig, LLP
News GRAM acquires nearby Grand Rapids property to support ongoing expansion Dec 06, 2022 Posted by Grand River Aseptic Manufacturing
News Navigator – Enhancing Life Sciences organizational growth with process and systems compliance & validation Dec 02, 2022
News ultra-low temperature chamber units in-house in 18 business days (including a national holiday! Dec 02, 2022 Posted by Grand River Aseptic Manufacturing
News 52 Greenberg Traurig Boston Attorneys Named ‘Top Lawyers’ by Boston Magazine Dec 02, 2022 Posted by Greenberg Traurig, LLP
News Mispro to open contract vivarium in Boston’s biotech-dense Seaport district Nov 29, 2022 Posted by Mispro
